Hereditary amyloidoses associated with transthyretin mutations;Transthyretinassoziierte hereditäre amyloidosen

Nervenarzt

Volumn 73, Issue 10, 2002, Pages 930-936

  Hund, E ^a   Singer, R ^a   Linke, R P ^b   Willig, F ^c   Grau, A ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^c Krankenhaus Speyererhof Heidelberg   (Germany)

Author keywords

Amyloid; Mutation; Polyneuropathy; Transplantation; Transthyretin

Indexed keywords

ANTHRACYCLIN 4' IODO 4' DEOXYDOXORUBICIN; ANTHRACYCLINE DERIVATIVE; IODOX; METHIONINE; PREALBUMIN; UNCLASSIFIED DRUG; VALINE;

AMINO ACID SUBSTITUTION; AUTONOMIC DYSFUNCTION; AUTOSOMAL DOMINANT INHERITANCE; CARDIOMYOPATHY; CARPAL TUNNEL SYNDROME; CLINICAL FEATURE; DISEASE ASSOCIATION; FAMILIAL AMYLOIDOSIS; GASTROINTESTINAL SYMPTOM; GENE MUTATION; HUMAN; KIDNEY FAILURE; LIVER TRANSPLANTATION; ONSET AGE; POLYNEUROPATHY; REVIEW; TREATMENT INDICATION; VITREOUS OPACITY;

AMYLOID NEUROPATHIES, FAMILIAL; AMYLOIDOSIS, FAMILIAL; CHROMOSOME ABERRATIONS; DNA MUTATIONAL ANALYSIS; GENES, DOMINANT; HUMANS; NEUROLOGIC EXAMINATION; PREALBUMIN;

EID: 0036937950     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00115-002-1345-9     Document Type: Review

References (78)

1. Adams D,Sanuel D,Goulon-Goeau C et al. (2000) The course and prognostic factors of familial amyloid polyneuropathy after liver transplantation. Brain 123:1495-1504
2. Almeida MR, Alves IL,Terazaki H, Ando Y, Saraiva MJM (2000) Comparative studies of two transthyretin variants with protective effects on familial amyloidotic polyneuropathy: TTR R104H and TTRT119 M. Biochem Biophys Res Commun 270:1024-1028
3. Almeida MR, Aoyama-Oishi N, Sakaki Y et al. (1995) Haplotype analysis of common transthyretin mutations. Hum Genet 96:350-354
4. Altland K,Winter P (1999) Potential treatment of transthyretin-type amyloidoses by sulfite. Neurogenetics 2:183-188
5. Altland K,Winter P, Sauerborn MK (1999) Electrically neutral microheterogeneity of human plasma transthyretin (prealbumin) detected by isoelectric focusing in urea gradients. Electrophoresis 20:1349-1364.
6. Alves IL, Altland K, Almeida MR, Winter P, Saraiva MJM (1997) Screening and biochemical characterization of transthyretin variants in the Portuguese population. Hum Mutat 9:226-233
7. Azoulay D, Samuel D, Adam R et al. (2000) Paul Brousse Liver Transplantation: the first 1,500 cases. Clin Transpl 273-280
8. Barros J, Coelho T, Lobato L, Sousa A (1996) Unusual phenotypic variability within the same family: variable penetrance and variable clinical expression. Neuromusc Disord 6 [Suppl 1]:39
9. Baures PW, Oza VB, Peterson SA, Kelly JW (1999) Synthesis and evaluation of inhibitors of transthyretin amyloid formation based on the non-steroidal anti-inflammatory drug, flufenamic acid. Bioorg Med Chem 7:1339-1347
10. Benson MD (1995) Amyloidosis. In: Scriver CR, Beaudet AL, Sly WS,Valle D (eds) The metabolic and molecular basis of inherited disease. 7th edn Vol 3. McGraw-Hill, New-York, pp 4159-4191
11. Benson MD (1996) Leptomeningeal amyloid and variant transthyretins [comment]. Am J Pathol 148:351-354
12. Buxbaum JN, Tagoe CE (2000) The genetics of the amyloidoses. Annu Rev Med 51:543-569
13. Carvalho MJ, Lobato L, Ventura A et al. (2000) Remission of proteinuria following liver transplantation for familial amyloid polyneuropathy TTR met30. Transplant Proc 32:2664-2666.
14. Chiti F, Webster P, Taddei N et al. (1999) Designing conditions for in vitro formation of amyloid protofilaments and fibrils [see comments]. Proc Natl Acad Sci USA 96:3590-3594
15. Coelho T, Sousa A, Lourenco E, Ramalheira J (1994) A study of 159 Portuguese patients with familial amyloidotic polyneuropathy (FAP) whose parents were both unaffected. J Med Genet 31:293-299
16. de Carvalho M, Moreira P, Evangelista T, Ducla-Soares JL, Bento M, Fernandes R, Saraiva MJM (2000) New transthyretin mutation V28 M in a Portuguese kindred with amyloid polyneuropathy. MuscleNerve 23:1016-1021
17. Delank HW, Kutzner M (1982) Verlaufsbeobachtungen bei hereditärer Amyloidpolyneuropathie. Nervenarzt 53:603-607
18. Dubrey SW, Davidoff R, Skinner M, Bergethon P, Lewis D, Falk RH (1997) Progression of ventricular wall thickening after liver transplantation for familial a myloidosis. Transplantation 64:74-80
19. Dupuy O, Bletry O, Blanc AS, Droz D,Viemont M, Delpech M, Grateau G (1998) A novel variant of transthyretin (Glu42Asp) associated with sporadic late-onset cardiac amyloidosis. Amyloid 5:285-287
20. Ellie E, Camou F, Vital A, Rummens C, Grateau G, Delpech M, Valleix S (2001) Recurrent subarachnoid hemorrhage associated with a new transthyretin variant (Gly53Glu). Neurology 57:135-137.
21. Fändrich M, Fletcher MA, Dobson CM (2001) Amyloid fibrils from muscle myoglobin. Nature 410:165-166.
22. Feurle G, Niemöller K (1978) Eine neuentdeckte Sippe mit hereditärer Amyloidneuropathie. Nachweis vermehrter enteraler Dekonjugation von Gallensäuren. Schweiz Med Wochenschr 108:673-680
23. Frangione B,Vidal R, Rostagno A, Ghiso J (2000) Familial cerebral amyloid angiopathies and dementia. Alzheimer Dis Assoc Disord 14:525-30.
24. Garcia Herola A, Prieto M, Pascual S et al. (1999) Progression of cardiomyopathy and neuropathy after liver transplantation in a patient with familial amyloidotic polyneuropathy caused by tyrosine-77 transthyretin variant. Liver Transpl Surg 5:246-248
25. Golling M, Singer R, Weiss G et al. (2000) Sequential (domino) transplantation of the liver in a transthyretin-5O familial amyloid polyneuropathy. Special reference to cardiological diagnosis and complications. Langenbecks Arch Surg 385:21-26
26. Grateau G (1998) Familial mediterranean fever: from inflammation to amyloidosis. Nephrol Dial Transplant 13:1919-1920
27. Hafer-Macko CE, Dyck PJ, Koski CL (2000) Complement activation in acquired and hereditary amyloid neuropathy. J Peripher Nerv Syst 5:131-139
28. Hammarstrom P, Schneider F, Kelly JW (2001) Trans-suppression of misfolding in an amyloid disease. Science 293:2459-2462
29. Herlenius G, Larsson M, Ericzon BG (2001) Results from the familial amyloidotic polyneuropathy world transplant registry. Transplant Proc 33:2454
30. Herrick MK, DeBruyne K, Horoupian DS, Skare J, Vanefsky MA, Ong T (1996) Massive leptomeningeal amyloidosis associated with a Val30Met transthyretin gene. Neurology 47:988-992
31. Hesse A, Altland K, Linke RP, Almeida MR, Saraiva MJM, Steinmetz A, Maisch B (1993) Cardiac amyloidosis: a review and report of a new transthyretin (prealbumin) variant. Br Heart J 70:111-115
32. Holmgren G, Ando Y, Wikström L, Rydh A, Suhr O (1997) Discordant symptoms in monocygotic twins with familial amyloidotic polyneuropathy (FAP). Amyloid 4:178-180
33. Hund E, Altland K, Grau A, Bläker H, Krempien S, Singer R, Willig F (1999) Hereditary amyloidosis TTR-Val107: a rare variant with late onset. Pathol Res Pract 195:372
34. Hund E, Linke RP Willig F, Grau A (2001) Transthyretin-associated neuropathic amyloidosis. Neurology 56:431-435
35. a. Iversen L (2002) Small drugs lead the attack. Nature 417:231-233
36. Jacobson DR, Pastore RD,Yaghoubian R,Kane I, Gallo G, Buck FS, Buxbaum JN (1997) Variantsequence transthyretin (isoleucine 122) in lateonset cardiac amyloidosis in black Americans [see comments]. N Engl J Med 336:466-473
37. Jenne DE, Denzel K, Blätzinger P, Winter P, Obermaier B, Linke RP, Altland K (1996) A new isoleucine substitution of Val-20 in transthyretin tetramers selectively impairs dimer-dimer contacts and causes systemic amyloidosis. Proc Natl Acad Sci USA 93:6302-6307
38. Klein CJ, Nakumura M, Jacobson DR,Lacy MQ, Benson MD, Petersen RC (1998) Transthyretin amyloidosis (serine 44) with headache, hearing loss, and peripheral neuropathy. Neurology 51:1462-1464
39. Lansbury PT Jr, Togashi S,Watanabe H et al. (1999) Evolution of amyloid: what normal protein folding may tell us about fibrillogenesis and disease [comment]. Proc Natl Acad Sci USA 96:3342-3344
40. Lim A, Prokaeva T, McComb ME, O'Connor PB, Theberge R,Connors LH, Skinner M,Costello CE (2002) Characterization of transthyretin variants in familial transthyretin amyloidosis by mass spectrometric peptide mapping and DNA sequence analysis. Anal Chem 74:741-751
41. Linke RP, Altland K, Ernst J,Gerhard L, Michels H, Saeger W, Willig F (1998) Praktische Hinweise zur Diagnose und Therapie generalisierter Amyloidosen. Dtsch Ärztebl 95:2626-2636
42. Mascalchi M, Salvi F, Pirini MG et al. (1999) Transthyretin amyloidosis and superficial siderosis of the CNS. Neurology 53:1498-1503
43. Munar-Ques M, Salva-Ladaria L, Mulet-Perera P, Sole M, Lopez-Andreu FR, Saraiva MJM (2000) Vitreous amyloidosis after liver transplantation in patients with familial amyloid polyneuropathy: ocular synthesis of mutant transthyretin. Amyloid 7:266-269
44. Munar-Ques M, Saraiva MJM, Ordeig-Calonge J et al. (2000) Familial amyloid polyneuropathy in a Spanish family with a transthyretin deletion (deltaVal 122) presenting with carpal tunnel syndrome. Clin Genet 58:411-412
45. Murakami T, Tachibana S, Endo Y, Kawai R, Hara M, Tanase S, Ando M (1994) Familial carpal tunnel syndrome due to amyloidogenic transthyretin His 114 variant. Neurology 44:315-318
46. Neundörfer B, Kuhn H (1975) Familiäre Amyloidpolyneuropathie vom portugiesischen Typ. Bericht über eine im südhessischen Raum ansässige Sippe. Nervenarzt 46:177-182
47. Palha JA, Ballinari D, Amboldi N et al. (2000) 4'-lodo-4'-deoxydoxorubicin disrupts the fibrillar structure of transthyretin amyloid. Am J Pathol 156:1919-1925
48. Petersen RB, Goren H,Cohen M et al. (1997) Transthyretin amyloidosis: a new mutation associated with dementia. Ann Neurol 41:307-313
49. Peterson SA, Klabunde T, Lashuel HA, Purkey H, Sacchettini JC, Kelly JW (1998) Inhibiting transthyretin conformational changes that lead to amyloid fibril formation. Proc Natl Acad Sci USA 95:12956-12960
50. Planté-Bordeneuve V, Lalu T, Misrahi M, Reilly MM, Adams D, Lacroix C, Said G (1998) Genotypic-phenotypic variations in a series of 65 patients with familial amyloid polyneuropathy. Neurology 51:708-714
51. Poepel B, Seibert V, Steiner H, Knorz MC, Willig F, Liesenhoff H (1994) Clinical and pathohistological ocular findings in a patient with familial amyloid polyneuropathy of the portuguese type. Invest Ophthalmol Vis Sci 35:1446
52. Quintas A, Vaz DC,Cardoso I, Saraiva MJM, Brito RM (2001)Tetramer dissociation and monomer partial unfolding precedes protofibril formation in amyloidogenic transthyretin variants. J Biol Chem 276:27207-27213
53. Reilly MM, Adams D, Booth DR et al. (1995) Transthyretin gene analysis in European patients with suspected familial amyloid polyneuropathy. Brain 118:849-856
54. Reilly MM, Staunton H (1996) Peripheral nerve amyloidosis. Brain Pathol 6:163-177
55. Reilly MM, Staunton H, Harding AE (1995) Familial amyloid polyneuropathy (TTR ala 60) in north west Ireland: a clinical, genetic,and epidemiological study. J Neurol Neurosurg Psychiatry 59:45-49
56. Sakashita N, Ando Y, Jinnouchi K, Yoshimatsu M, Terazaki H, Obayashi K,Takeya M (2001) Familial amyloidotic polyneuropathy (ATTR Val30Met) with widespread cerebral amyloid angiopathy and lethal cerebral hemorrhage. Pathol Int 51:476-480
57. Saraiva MJM (2001) Transthyretin amyloidosis: a tale of weak interactions. FEBS Lett 498:201-203
58. Seddigh S, Dahmen N, Goebel HH, Hopf HC, Benson MD (1999) Hinweise auf einen gemeinsamen Ursprung einer deutschen und amerikanischen Familie mit hereditärer Amyloidneuropathie Typ II. Nervenarzt 70:899-902
59. Shaz BH, Gordon F, Lewis WD, Jenkins RL, Skinner M, Khettry U (2000) Orthotopic liver transplantation for familial amyloidotic polyneuropathy: a pathological study. Hum Pathol 31:40-44
60. Singer R,Altland K, Hofmann W, Linke RP, Otto G, Willig F (1997) Lebertransplantation bei familiärer Polyneuropathie. Verh Dtsch Ges Path 81:703
61. Soares M, Buxbaum J, Sirugo G et al. (1999) Genetic anticipation in Portuguese kindreds with familial amyloidotic polyneuropathy is unlikely to be caused by triplet repeat expansions. Hum Genet 104:480-485
62. Soto C (2001) Protein misfolding and disease; protein refolding and therapy. FEBS Lett 498:204-207
63. Sousa A, Andersson R,Drugge U, Holmgren G, Sandgren O (1993) Familial amyloidotic polyneuropathy in Sweden: geographical distribution, age of onset, and prevalence. Hum Hered 43:288-294
64. Sousa A, Coelho T, Barros J, Sequeiros J (1995) Genetic epidemiology of familial amyloidotic polyneuropathy (FAP)-type I in Povoa do Varzim and Vila do Conde (north of Portugal). Am J Med Genet 60:512-521
65. Sousa MM, Du Yan S, Fernandes R, Guimaraes A, Stern D, Saraiva MJM (2001) Familial amyloid polyneuropathy: receptor for advanced glycation end products-dependent triggering of neuronal inflammatory and apoptotic pathways. J Neurosci 21:7576-7586
66. Sousa MM, Yan SD, Stern D, Saraiva MJM (2000) Interaction of the receptor for advanced glycation end products (RAGE) with transthyretin triggers nuclear transcription factor kB (NF-kB) activation. Lab Invest 80:1101-1110
67. Stangou AJ, Hawkins PN, Heaton ND et al. (1998) Progressive cardiac amyloidosis following liver transplantation for familial amyloid polyneuropathy: implications for amyloid fibrillogenesis. Transplantation 66:229-233
68. Stangou AJ, Heaton ND, Rela M, Pepys MB, Hawkins PN, Williams R (1998) Domino hepatic transplantation using the liver from a patient with familial amyloid polyneuropathy. Transplantation 65:1496-1498
69. Suhr OB,Ando Y, Holmgren G,Wikstrom L, Friman S, Herlenius G, Ericzon BG (1998) Liver transplantation in familial amyloidotic polyneuropathy (FAP). A comparative study of transplanted and non-transplanted patient's survival. Transpl Int 11:160-163
70. Suhr OB, Herlenius G, Friman S, Ericzon BG (2000) Liver transplantation for hereditary transthyretin amyloidosis. Liver Transpl 6:263-276
71. Terazaki H, Ando Y, Misumi S et al.(1999) A novel compound heterozygote (FAP ATTR Arg104His/ATTR Val30Met) with high serum transthyretin (TTR) and retinol binding protein (RBP) levels. Biochem Biophys Res Commun 264:365-370
72. Tietz A (2000) Hereditäre Amyloidose im Mannheimer Norden. Medizinische Fakultät der Universität Heidelberg
73. Togashi S, Watanabe H, Nagasaka T et al. (1999) An aggressive familial amyloidotic polyneuropathy caused by a new variant transthyretin Lys 54. Neurology 53:637-639
74. Uemichi T, Liepnieks JJ, Benson MD (1997) A trinucleotide deletion in the transthyretin gene (delta V 122) in a kindred with familial amyloidotic polyneuropathy. Neurology 48:1667-1670
75. Westermark P, Sletten K,Johansson B, Cornwell GG, 3rd (1990) Fibril in senile systemic amyloidosis is derived from normal transthyretin. Proc Natl Acad Sci USA 87:2843-2845
76. White JT, Kelly JW (2001) Support for the multigenic hypothesis of amyloidosis: The binding stoichiometry of retinol-binding protein, vitamin A, and thyroid hormone influences transthyretin amyloidogenicity invitro. Proc Natl Acad Sci USA 98:13019-13024
77. Yamamoto K, Hsu SP, Yoshida K et al. (1994) Familial amyloid polyneuropathy in Taiwan: identification of transthyretin variant (LeuSSPro). Muscle Nerve 17:637-641
78. Yasuda T, Sobue G, Doyu M, Nakazato M, Shiomi K, Yanagi T, Mitsuma T (1994) Familial amyloidotic polyneuropathy with late-onset and well-preserved autonomic function: a Japanese kindred with novel mutant transthyretin (Ala97 to Gly). J Neurol Sci 121:97-102